Design Therapeutics (DSGN) Income Statement: Revenue & Earnings

Design Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Design Therapeutics, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.23
Cost of Revenue	0.60	57.06	48.61	24.78	6.06
Gross Profit	-0.60	-57.06	-48.61	-24.78	-5.83
Operating Expenses
Research & Development	44.35	57.06	48.61	24.78	0.00
Selling, General & Administrative	18.03	21.13	18.98	11.05	2.50
Operating Expenses	61.79	78.19	18.98	11.05	2.50
Operating Income	-62.38	-78.19	-67.59	-35.83	-8.33
Other Income/Expense
Interest Income	12.80	11.33	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	12.80	11.33	2.89	0.22	-0.02
Income
Income Before Tax	-49.59	-66.86	-63.31	-35.53	-8.28
Income Tax Expense	0.00	-0.04	-0.20	-0.01	0.00
Net Income	-49.59	-66.86	-63.31	-35.53	-8.28
Net Income - Continuous Operations	-49.59	-66.86	-63.31	-35.53	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-48.99	-77.65	-67.19	-35.70	-8.33
EBIT	-62.38	-78.19	-67.59	-35.83	-8.33
Depreciation & Amortization	0.60	0.54	0.41	0.13	0.01
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	56.59	55.98	55.71	45.94	15.80
Diluted Shares Outstanding	56.59	55.98	55.71	45.94	15.80